| A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer TS Solheim, BJA Laird, TR Balstad, GB Stene, A Bye, N Johns, ... Journal of cachexia, sarcopenia and muscle 8 (5), 778-788, 2017 | 293 | 2017 |
| Effect of physical exercise on muscle mass and strength in cancer patients during treatment—a systematic review GB Stene, JL Helbostad, TR Balstad, II Riphagen, S Kaasa, LM Oldervoll Critical reviews in oncology/hematology 88 (3), 573-593, 2013 | 242 | 2013 |
| Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial TS Solheim, BJA Laird, TR Balstad, A Bye, G Stene, V Baracos, F Strasser, ... BMJ supportive & palliative care 8 (3), 258-265, 2018 | 174 | 2018 |
| Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review TR Balstad, TS Solheim, F Strasser, S Kaasa, A Bye Critical reviews in oncology/hematology 91 (2), 210-221, 2014 | 124 | 2014 |
| Coffee, broccoli and spices are strong inducers of electrophile response element‐dependent transcription in vitro and in vivo – Studies in electrophile response … TR Balstad, H Carlsen, MCW Myhrstad, M Kolberg, H Reiersen, L Gilen, ... Molecular nutrition & food research 55 (2), 185-197, 2011 | 100 | 2011 |
| Extract of oregano, coffee, thyme, clove, and walnuts inhibits NF-κB in monocytes and in transgenic reporter mice I Paur, TR Balstad, M Kolberg, MK Pedersen, LM Austenaa, DR Jacobs Jr, ... Cancer Prevention Research 3 (5), 653-663, 2010 | 89 | 2010 |
| Degree of roasting is the main determinant of the effects of coffee on NF-κB and EpRE I Paur, TR Balstad, R Blomhoff Free Radical Biology and Medicine 48 (9), 1218-1227, 2010 | 88 | 2010 |
| A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer OM Vagnildhaug, TR Balstad, SS Almberg, C Brunelli, AK Knudsen, ... Supportive Care in Cancer 26, 1871-1880, 2018 | 71 | 2018 |
| A systematic review examining nutrition support interventions in patients with incurable cancer HA Blackwood, CC Hall, TR Balstad, TS Solheim, M Fallon, ... Supportive Care in Cancer 28, 1877-1889, 2020 | 62 | 2020 |
| Effects of current parenteral nutrition treatment on health-related quality of life, physical function, nutritional status, survival and adverse events exclusively in patients … R Tobberup, L Thoresen, UG Falkmer, MK Yilmaz, TS Solheim, ... Critical Reviews in Oncology/Hematology 139, 96-107, 2019 | 54 | 2019 |
| Patient interpretation of the patient-generated subjective global assessment (PG-SGA) short form TR Balstad, A Bye, CRS Jenssen, TS Solheim, L Thoresen, K Sand Patient preference and adherence, 1391-1400, 2019 | 51 | 2019 |
| Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux IO Ottestad, B Halvorsen, TR Balstad, K Otterdal, GI Borge, F Brosstad, ... The Journal of nutrition 136 (4), 877-881, 2006 | 48 | 2006 |
| Exercise and nutrition interventions in patients with head and neck cancer during curative treatment: a systematic review and meta-analysis A Bye, JA Sandmael, GB Stene, L Thorsen, TR Balstad, TS Solheim, ... Nutrients 12 (11), 3233, 2020 | 47 | 2020 |
| Development of the EORTC QLQ-CAX24, a questionnaire for cancer patients with cachexia SJ Wheelwright, JB Hopkinson, AS Darlington, DF Fitzsimmons, P Fayers, ... Journal of pain and symptom management 53 (2), 232-242, 2017 | 47 | 2017 |
| Activation and inhibition of nuclear factor kappa B activity by cereal extracts: role of dietary phenolic acids AS Hole, S Grimmer, K Naterstad, MR Jensen, I Paur, SG Johansen, ... Journal of agricultural and food chemistry 57 (20), 9481-9488, 2009 | 29 | 2009 |
| Deterioration in muscle mass and physical function differs according to weight loss history in cancer cachexia GB Stene, TR Balstad, ASM Leer, A Bye, S Kaasa, M Fallon, B Laird, ... Cancers 11 (12), 1925, 2019 | 27 | 2019 |
| Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function TR Balstad, KB Holven, IO Ottestad, K Otterdal, B Halvorsen, AM Myhre, ... Clinica chimica acta 359 (1-2), 171-178, 2005 | 25 | 2005 |
| Endpoints in clinical trials in cancer cachexia: where to start? BJA Laird, TR Balstad, TS Solheim Current Opinion in Supportive and Palliative Care 12 (4), 445-452, 2018 | 20 | 2018 |
| Multimodal nutrition/anabolic therapy for wasting conditions TR Balstad, S Kaasa, TS Solheim Current Opinion in Clinical Nutrition & Metabolic Care 17 (3), 226-235, 2014 | 19 | 2014 |
| Linguistic and content validation of the translated and culturally adapted PG-SGA, as perceived by Norwegian cancer patients and healthcare professionals C Henriksen, L Thoresen, B Fjøseide, SS Lorentzen, TR Balstad, ... Clinical nutrition ESPEN 38, 178-184, 2020 | 18 | 2020 |
